Literature DB >> 6138228

Metabolism of harmol and transport of harmol conjugates in isolated rat hepatocytes.

D W Sundheimer, K Brendel.   

Abstract

The conjugation of harmol and the disposition of harmol metabolites by isolated rat hepatocytes were investigated. Harmol sulfation was saturated at very low concentrations and exhibited a maximum velocity of 1.2 +/- 0.2 nmol/min/10(6) hepatocytes. Glucuronidation of harmol proceeded with a Km of 17 +/- 5.7 microM and a maximal velocity of 2.1 +/- 0.3 nmol/min/10(6) hepatocytes. After synthesis, harmol glucuronide and harmol sulfate were distributed between cells and incubation media, and at equilibrium, a large concentration gradient between cells and media existed for both conjugates. Experiments with preformed metabolites indicated that hepatocytes removed harmol glucuronide from the incubation media by single Michaelis-Menten process with a Km of 384 +/- 63 microM and Vmax of 1.8 +/- 0.3 nmol/min/10(6) hepatocytes. Harmol sulfate was taken up by two Michaelis-Menten processes, a high affinity process with a Km of 33 +/- 8 microM and a Vmax of 0.97 +/- 0.2 nmol/min/10(6) cells and a low affinity process with a Km of 452 +/- 71 microM and Vmax of 25.2 +/- 4.1/min/10(6) hepatocytes. Harmol sulfate was released from hepatocytes by a process which did not exhibit saturation. Hepatocytes converted preformed harmol glucuronide to harmol sulfate.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6138228

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  4 in total

1.  Hepatic conjugation/deconjugation cycling pathways. Computer simulations examining the effect of Michaelis-Menten parameters, enzyme distribution patterns, and a diffusional barrier on metabolite disposition.

Authors:  S B Hansel; M E Morris
Journal:  J Pharmacokinet Biopharm       Date:  1996-04

2.  Effect of a diffusional barrier to a metabolite across hepatocytes on its kinetics in "enzyme-distributed" models: a computer-aided simulation study.

Authors:  S Miyauchi; Y Sugiyama; H Sato; Y Sawada; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1987-08

3.  Evidence for an UDP-glucuronic acid/phenol glucuronide antiport in rat liver microsomal vesicles.

Authors:  G Bánhegyi; L Braun; P Marcolongo; M Csala; R Fulceri; J Mandl; A Benedetti
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

4.  Sex differences in the biotransformation of 2-acetylaminofluorene in cultured rat hepatocytes.

Authors:  C A McQueen; M J Miller; G M Williams
Journal:  Cell Biol Toxicol       Date:  1986-06       Impact factor: 6.691

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.